Company intelligence / Profile preview

ObelysQ

Milvignes, Neuchâtel, Switzerlandobelysq.com ↗

Ownership: Private
Employees: ~10
Development stage: Other

Overview

ObelysQ is a leading Swiss-based consulting firm specializing in Good Clinical Practice (GCP) and Good Pharmacovigilance Practice (GVP) quality assurance for the pharmaceutical industry. The company provides tailored solutions to optimize compliance, support regulatory inspections, conduct audits, develop SOPs, deliver training, perform gap analyses, assist with EU CTR implementation, and advise on data protection. With over 15 years of expertise per team member and more than 60 clients globally after four years of operation, ObelysQ is recognized for its excellence in enhancing clinical trial execution.

Therapeutic areas: Other
Modalities: Not directly applicable (consulting/services company, not a therapeutic developer)
Industry: Consulting

Partnerships

Intagest Consulting Solutions – partnership for EU CTR implementation support

Beyond the preview

Go deeper on ObelysQ.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ObelysQ.

Explore the full profile